Funds and ETFs Australian Clinical Labs Limited

Equities

ACL

AU0000148496

Healthcare Facilities & Services

Market Closed - Australian S.E. 02:10:46 2024-04-30 am EDT 5-day change 1st Jan Change
2.43 AUD -0.82% Intraday chart for Australian Clinical Labs Limited -0.41% -15.92%

ETFs positioned on Australian Clinical Labs Limited

Name Weight AuM 1st Jan change Investor Rating
0.03% 2 M€ -.--%
0.01% 7 M€ -.--% -
0.00% 10 M€ -3.35% -
Australian Clinical Labs Limited is a private provider of pathology services. Its laboratories perform a range of pathology tests each year for a range of clients, including doctors, specialists, patients, hospitals, and corporate clients. It performs a range of services for doctors, patients, and corporate clients, including routine pathology tests, advanced molecular genetics testing, harmony NIPT and first trimester screening, genetic carrier screening, chemical pathology, histopathology and cytopathology, hematology, allergy and immunology, serology and microbiology, infectious molecular testing, cardiac testing services, functional pathology, veterinary pathology, and commercial drug and alcohol testing. Its specialist services include molecular cancer services, obstetrics and gynecology, pharmacogenetic testing, gastroenterology, and hospital services. It has operations in Victoria, New South Wales, Western Australia, South Australia, Queensland, and the Northern Territory.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
2.45 AUD
Average target price
3.096 AUD
Spread / Average Target
+26.36%
Consensus
  1. Stock Market
  2. Equities
  3. ACL Stock
  4. Funds and ETFs Australian Clinical Labs Limited